SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.400+1.7%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jargonweary who wrote (1131)8/14/2025 5:57:29 PM
From: bobbseytwins20016 Recommendations

Recommended By
CCS648
Davidoff
End2War
erippetoe
mannamal

and 1 more member

  Read Replies (1) of 1216
 
Come on guys! These people are trying to run a small biotech company, and they won't care much about the stock price until they are good and ready, and want or need it to move up. The short sellers remain in control for now. In the meantime they are executing well in the way they choose to. When IMMU was on the bottom we all would have died to see this kind of progress steadily being made. To us this is a real investment where we can expect or hope for continuous better news in the future, and at $2.70 we can't see much risk with an approved product on the market and sales ramping up. We are bullish,
although the biotech bear has lasted years too long.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News